Net Income

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

A new 'zero-disruption' plate from TheWell Bioscience aims to solve key challenges in organoid research, promising more reliable data for drug discovery.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Safe Harbor Financial secures a landmark deal with PCCU, boosting revenue by $9M but taking on more risk. A bold move in the evolving cannabis finance world.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

Universal Corporation appoints Steven Diel, the mind behind its ingredients push, as CFO, signaling a firm commitment to diversification despite headwinds.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

Guardforce AI aims to acquire a leading speech therapy platform, signaling a major strategic pivot from secured logistics to the booming AI healthcare market.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

With five conferences in its sights, Voyager Therapeutics is making a major push to win over investors ahead of a pivotal year for its neurological pipeline.

A new report reveals AI-themed ads failed to connect with viewers, while heartfelt, human-centric stories from brands like the NFL and Budweiser won the night.

The private jet operator posted record revenue with fewer planes, achieving its first-ever quarter of positive Adjusted EBITDA in a major turnaround.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

After a decade transforming the UK's largest care provider, Safanad's sale to Welltower signals a major shift in global investment towards the Gulf.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

As new EU laws on AI and sustainability take full effect, over 250 compliance leaders will meet in Berlin to forge strategies for navigating the risks.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.